 TORONTO, ON ACCESSWIRE March 12, 2020 Edesa Biotech, Inc. EDSA, a clinical-stage biopharmaceutical company, today announced a collaborative research project with the National Research Council of Canada NRC to develop novel immunotherapies for vitiligo as well as other indications. Vitiligo 